4.4 Letter

Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk

Journal

HAEMATOLOGICA
Volume 105, Issue 9, Pages E480-E483

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2019.236588

Keywords

-

Categories

Funding

  1. National Institutes of Health, National Cancer Institute [PO1-155258, P50-100707]
  2. Cancer Pharmacology of Toulouse and Region (CAPTOR) program
  3. Fondation ARC (Association pour la Recherche sur la Cancer) [PGA1*20160203788]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available